Drugs News and Research

RSS

Drug company pipelines are filling up with new molecules to help people lose weight

Drugs that promise to help people lose weight have had a checkered past, such as the infamous fen-phen that was pulled from the market in 1997 after reports of heart valve damage. But now, drug company pipelines are filling up with new molecules that aim to help people safely shed extra pounds, according to a cover story in Chemical & Engineering News, an independent news outlet of the American Chemical Society.

21 Oct 2021

Researchers develop a new method to remove old cells from tissues to slow down aging

No one knows why some people age worse than others and develop diseases -such as Alzheimer's, fibrosis, type 2 diabetes or some types of cancer- associated with this ageing process.

20 Oct 2021

Personalized clotting profiles could benefit people at risk from strokes and heart attacks

People at risk from strokes and heart attacks could benefit from personalized clotting profiles to help clinicians prescribe more precise treatments, thanks to new research.

20 Oct 2021

Discovery could lead to new treatments for axial spondyloarthritis

In a paper published today in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute, part of University Health Network in Toronto, have made a discovery that could lead to new treatments for axial spondyloarthritis (SpA), a painful and debilitating form of arthritis which affects 1-2% of Canadians and causes inflammation in the spine, joints, eyes, gut and skin.

20 Oct 2021

Study offers clues to why calorie-restricted diet may slow tumor growth

In recent years, there has been some evidence that dietary interventions can help to slow the growth of tumors.

20 Oct 2021

Public and environmental health effects of the pandemic revealed by chemical analyses of wastewater

When investigators analyzed primary sludge collected during the first wave of COVID-19 (March 19 to June 30, 2020) at a wastewater treatment plant in Connecticut, they found trends in the presence of chemicals that related directly to the pandemic - for example, hydroxychloroquine had elevated concentrations in the week following Emergency Use Authorization of the drug for the treatment of COVID-19.

20 Oct 2021

New shorter treatment regimen found to be safer, more effective at treating drug-resistant TB

A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced at the 52nd Union World Conference on Lung Health.

20 Oct 2021

Discovery could help develop a new treatment strategy for patients with melanoma

A new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity.

20 Oct 2021

UK government announces deals to secure two new COVID-19 treatments

Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government announced deals to secure two new treatments.

20 Oct 2021

Scientists search for cause of mysterious covid-related inflammation in children

Like most other kids with covid, Dante and Michael DeMaino seemed to have no serious symptoms.

20 Oct 2021

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

A group of researchers performed a drug repurposing screen on an FDA-approved anti-cancer drug named Mitoxantrone.

20 Oct 2021

Research may lead to breakthroughs in combating cancer drug resistances

New research has revealed the differences in mechanism behind cancer’s resistance to the major class of anti-cancer drugs known as nucleoside analogues.

20 Oct 2021

Collaborations and co-achievements of network of COST Actions on COVID-19

Addressing societal issues by enabling cross-disciplinary partnerships is an inherent part of a COST Actions' nature. But collaborations don't stop at the gate of these specific networks: multiple COST Actions have joined forces since the beginning of the pandemic to help advance research into COVID-19.

20 Oct 2021

Drugs News and Research

Drug company pipelines are filling up with new molecules to help people lose weight

Researchers develop a new method to remove old cells from tissues to slow down aging

Personalized clotting profiles could benefit people at risk from strokes and heart attacks

Discovery could lead to new treatments for axial spondyloarthritis

Study offers clues to why calorie-restricted diet may slow tumor growth

Public and environmental health effects of the pandemic revealed by chemical analyses of wastewater

New shorter treatment regimen found to be safer, more effective at treating drug-resistant TB

Discovery could help develop a new treatment strategy for patients with melanoma

UK government announces deals to secure two new COVID-19 treatments

Scientists search for cause of mysterious covid-related inflammation in children

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

Research may lead to breakthroughs in combating cancer drug resistances

Collaborations and co-achievements of network of COST Actions on COVID-19

Researchers discover new way to jump-start the immune system to attack tumors

Commonly prescribed medications can make the flu virus more or less active

Researchers identify the genetic changes responsible for drug resistance in tuberculosis

The biochemical mechanisms of remdesivir-mediated RNA synthesis inhibition

COVID-19 vaccine breakthrough infections among immunocompromised individuals

Structural mechanism of anti-SARS-CoV-2 neutralizing antibodies that target separate spike epitopes

Sino Biological, Inc. to be featured on worldwide business with Kathy Ireland®

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News